Nextech Invest's Stella Paffenholz on finding opportunities during difficult markets
Action Potential Venture Capital's Imran Eba describes the field of bioelectronic medicine
Genezen's CEO discusses the current supply situation in viral vector manufacturing
Vida Ventures' Arjun Goyal shares his thoughts on the current environment in biotech
Brushing up on the science of obesity with Rhythm Pharmaceuticals’ CEO
Canaccord Genuity’s Bill Maughan joins BiotechTV for Analyst Thursdays
Nobel laureate Carolyn Bertozzi walks us through the science of glyco-immunology
Monte Rosa's CEO discusses yesterday's data for MRT-2359 in MYC-driven solid tumors
Amylyx's Co-CEOs comment on Friday's European CHMP decision on their ALS therapy
Evercore ISI’s Liisa Bayko joins BiotechTV for Analyst Thursdays
The CEO of eGenesis elaborates on today's Nature paper using pig kidneys for transplantation in NHPs
The Head of Bayer in the US on pharma and a new $250M cell Tx facility in Berkeley, CA. #HLTH2023
Analyzing Nanobiotix's P1 Head & Neck data for the radioenhancer NBTXR3 from #ASTRO2023
How a blood testing company is trying to shake the ghost of Theranos. #HLTH2023
Montai Health's CEO talks about using AI to develop small molecules at #HLTH2023
Sanofi's Head of Vaccines for North America on the future of vaccines at #HLTH2023
Delfi Diagnostics' team on launching the FirstLook Lung cancer blood screening test at #HLTH2023
An investor’s perspective on health tech with a16z’s Vineeta Agarwala at #HLTH2023
The Head of Novartis in the US talks about therapeutic areas of focus at #HLTH2023
Cleerly’s James Min talks about heart disease and improving cardiovascular imaging at #HLTH2023
.png){kind=logo}
